Obesity and Cardiovascular Disease: OMA Statement Reframes Risk Treatment
OMA’s 2026 practice statement links obesity to cardiovascular disease and details treatment strategies spanning lifestyle, medications, and surgery.
Trials, guidelines and practice across cardiovascular medicine.
Trials, guidelines and practice across cardiovascular medicine.